Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?

Anil John(Pushpagiri Medical College), Moutaz Derbala(Cornell University), Manik Sharma(Hamad General Hospital), Ragesh Babu(Hamad Medical Corporation), Rafie Yacoub(Hamad Medical Corporation), Sanjay Doiphode(Hamad Medical Corporation), Saad Al Kaabi(Hamad General Hospital), Prem Chandra(Hamad Medical Corporation)

Indian Journal of Gastroenterology

September 1, 2015

10.1007/s12664-015-0604-1

Cited by 7

Related Papers

Artificial intelligence in medical education - perception among medical students

|BMC Medical Education|2024|121

Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study

|Lara D. Veeken|2012|106

Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study

|Journal of Gastroenterology and Hepatology|2005|73

Quality of Life, Sleep Quality, Depression, Anxiety, Stress, Eating Habits, and Social Bounds in Nurses during the Coronavirus Disease 2019 Pandemic in Qatar (The PROTECTOR Study): A Cross-Sectional, Comparative Study

|Journal of Personalized Medicine|2021|52

Perceived stress and post-traumatic stress disorder symptoms among intensive care unit staff caring for severely ill coronavirus disease 2019 patients during the pandemic: a national study

|Annals of General Psychiatry|2021|43